17-29475765-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_020791.4(TAOK1):āc.300A>Gā(p.Thr100Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000396 in 1,610,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.0021 ( 0 hom., cov: 32)
Exomes š: 0.00022 ( 0 hom. )
Consequence
TAOK1
NM_020791.4 synonymous
NM_020791.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.108
Genes affected
TAOK1 (HGNC:29259): (TAO kinase 1) Enables alpha-tubulin binding activity; beta-tubulin binding activity; and kinase activity. Involved in several processes, including mitotic G2 DNA damage checkpoint signaling; negative regulation of microtubule depolymerization; and positive regulation of JNK cascade. Located in microtubule cytoskeleton and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 17-29475765-A-G is Benign according to our data. Variant chr17-29475765-A-G is described in ClinVar as [Benign]. Clinvar id is 3056695.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.108 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00211 (322/152356) while in subpopulation AFR AF= 0.00745 (310/41584). AF 95% confidence interval is 0.00677. There are 0 homozygotes in gnomad4. There are 142 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 322 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAOK1 | NM_020791.4 | c.300A>G | p.Thr100Thr | synonymous_variant | 4/20 | ENST00000261716.8 | NP_065842.1 | |
TAOK1 | NM_025142.1 | c.300A>G | p.Thr100Thr | synonymous_variant | 4/18 | NP_079418.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00212 AC: 323AN: 152238Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
323
AN:
152238
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000543 AC: 135AN: 248724Hom.: 0 AF XY: 0.000417 AC XY: 56AN XY: 134410
GnomAD3 exomes
AF:
AC:
135
AN:
248724
Hom.:
AF XY:
AC XY:
56
AN XY:
134410
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000217 AC: 316AN: 1458144Hom.: 0 Cov.: 29 AF XY: 0.000190 AC XY: 138AN XY: 725374
GnomAD4 exome
AF:
AC:
316
AN:
1458144
Hom.:
Cov.:
29
AF XY:
AC XY:
138
AN XY:
725374
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00211 AC: 322AN: 152356Hom.: 0 Cov.: 32 AF XY: 0.00191 AC XY: 142AN XY: 74498
GnomAD4 genome
AF:
AC:
322
AN:
152356
Hom.:
Cov.:
32
AF XY:
AC XY:
142
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TAOK1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 06, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at